Tenenhouse H S, Jones G
Endocrinology. 1987 Feb;120(2):609-16. doi: 10.1210/endo-120-2-609.
The present study was undertaken to evaluate the response of Hyp mice to regulators known to inhibit renal 25-hydroxyvitamin D3-1-hydroxylase (1-hydroxylase) and stimulate renal 25-hydroxyvitamin D-24-hydroxylase (24-hydroxylase). Renal mitochondrial metabolism of 25-hydroxyvitamin D3 (25OHD3) was initially examined in vitamin D- and calcium-deprived normal and mutant mice (with no detectable 24-hydroxylase) treated with either calcium, 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3], or both calcium + 1,25-(OH)2D3. In normal mice, 1,25-(OH)2D3 treatment was more effective than calcium in turning off 1-hydroxylase and turning on 24-hydroxylase activity; serum calcium, however, was similarly increased by both treatments. Although calcium + 1,25-(OH)2D3 did not result in a further change in 25OHD3 metabolism in normal mice, a further elevation in serum calcium was apparent. In Hyp mice, treatment with calcium + 1,25-(OH)2D3 resulted in a greater decrease in 1-hydroxylase and a greater increase in 24-hydroxylase and in serum calcium than treatment with either agent alone. In spite of similar serum calcium levels in both genotypes, 24-hydroxylase was 20-fold, 3-fold, and 8-fold greater in Hyp mice relative to normals treated with calcium, 1,25-(OH)2D3, and calcium + 1,25-(OH)2D3, respectively. Kinetic studies revealed that the maximum velocity (Vmax) for induced 24-hydroxylase was 6-fold greater than normal in Hyp mice whereas the apparent Michaelis-Menten constant (Km) was not different in the two groups of calcium + 1,25-(OH)2D3-treated mice. The effect of 1,25-(OH)2D3 treatment on the above serum and renal parameters was also examined in vitamin D replete normal and Hyp mice. A sharp rise in serum phosphate was observed in 1,25-(OH)2D3-treated Hyp mice whereas normal littermates experienced marked hypercalcemia in response to treatment. Renal 24-hydroxylase was significantly stimulated by 1,25-(OH)2D3 treatment in both normal and Hyp mice and genotype differences were not apparent. The present study demonstrates that vitamin D- and calcium-deprived Hyp mice are more responsive to signals which induce 24-hydroxylase than normal littermates; Vmax for induced 24-hydroxylase is 6-fold greater in Hyp mice than in normal littermates whereas apparent Km is unchanged; the inhibitory control of 1-hydroxylase appears to be intact in the mutant strain; induced 24-hydroxylase is similar in vitamin D replete normal and Hyp mice; and vitamin D status can thus modify the response of both genotypes to treatment with 1,25-(OH)2D3.(ABSTRACT TRUNCATED AT 400 WORDS)
本研究旨在评估低血磷性佝偻病(Hyp)小鼠对已知可抑制肾25-羟维生素D3-1-羟化酶(1-羟化酶)并刺激肾25-羟维生素D-24-羟化酶(24-羟化酶)的调节剂的反应。最初在维生素D和钙缺乏的正常及突变小鼠(无可检测到的24-羟化酶)中检测25-羟维生素D3(25OHD3)的肾线粒体代谢,这些小鼠分别用钙、1,25-二羟维生素D3 [1,25-(OH)2D3]或钙 + 1,25-(OH)2D3进行处理。在正常小鼠中,1,25-(OH)2D3处理在关闭1-羟化酶和开启24-羟化酶活性方面比钙更有效;然而,两种处理使血清钙同样升高。虽然钙 + 1,25-(OH)2D3在正常小鼠中未导致25OHD3代谢的进一步变化,但血清钙有进一步升高。在Hyp小鼠中,与单独使用任何一种药物相比,钙 + 1,25-(OH)2D3处理导致1-羟化酶的降低幅度更大,24-羟化酶和血清钙的升高幅度更大。尽管两种基因型的血清钙水平相似,但相对于用钙、1,25-(OH)2D3和钙 + 1,25-(OH)2D3处理的正常小鼠,Hyp小鼠中的24-羟化酶分别高20倍、3倍和8倍。动力学研究表明,Hyp小鼠中诱导的24-羟化酶的最大速度(Vmax)比正常小鼠高6倍,而在两组钙 + 1,25-(OH)2D治疗的小鼠中,表观米氏常数(Km)没有差异。还在维生素D充足的正常和Hyp小鼠中研究了1,25-(OH)2D3处理对上述血清和肾脏参数的影响。在1,25-(OH)2D3处理的Hyp小鼠中观察到血清磷酸盐急剧升高,而正常同窝小鼠对处理的反应是明显的高钙血症。在正常和Hyp小鼠中,1,25-(OH)2D3处理均显著刺激肾24-羟化酶,且基因型差异不明显。本研究表明,维生素D和钙缺乏的Hyp小鼠比正常同窝小鼠对诱导24-羟化酶的信号更敏感;Hyp小鼠中诱导的24-羟化酶的Vmax比正常同窝小鼠高6倍,而表观Km不变;突变株中1-羟化酶的抑制性控制似乎完好无损;维生素D充足的正常和Hyp小鼠中诱导的24-羟化酶相似;因此,维生素D状态可改变两种基因型对1,25-(OH)2D3处理的反应。(摘要截短至400字)